Bio-Techne: Bio-Techne to Present at Investor Conferences

MINNEAPOLIS , Feb. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation TECH today announced that it will present at the following investor conferences: TD Cowen 45 th Annual Health Care Conference March 4, 2025 2:30 PM EST Leerink Partners Global Healthcare Conference March 11, 2025 11:20 AM EDT Barclays 27 th Annual Global Healthcare Conference March 12, 2025 10:00 AM EDT A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar . About Bio-Techne Bio-Techne Corporation TECH is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook , LinkedIn , Twitter or YouTube . Contact: David Clair , Vice President, Investor Relations & Corporate Development david.clair@bio-techne.com 612-656-4416 View original content to download multimedia: https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302387239.html SOURCE Bio-Techne Corporation © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.